The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium (Q40751138)

23 September 2017

title

The cost-effectiveness of pneumococcal vaccination in healthy adults over 50: An exploration of influential factors for Belgium (English)

1 reference

23 September 2017

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Lander Willem

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

author name string

Adriaan Blommaert

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Jan Verhaegen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Herman Goossens

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Philippe Beutels

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

language of work or name

English

0 references

publication date

14 March 2016

1 reference

23 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

2106-2112

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

1 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Vaccines for preventing pneumococcal infection in adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Streptococcus pneumoniae colonisation: the key to pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Epidemiology and outcome of invasive pneumococcal disease among adults in Belgium, 2009-2011.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Impact of the pneumococcal conjugate vaccines on invasive pneumococcal disease in France, 2001-2012.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Estimating the burden of pneumococcal pneumonia among adults: a systematic review and meta-analysis of diagnostic techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Cost-effectiveness of hepatitis A vaccination for adults in Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Cost-effectiveness of vaccination against herpes zoster in adults aged over 60 years in Belgium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Cost-effectiveness of seasonal influenza vaccination in pregnant women, health care workers and persons with underlying illnesses in Belgium.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

A review of economic evaluations of 13-valent pneumococcal conjugate vaccine (PCV13) in adults and the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2016.03.003

10.1016/J.VACCINE.2016.03.003

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26988257%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference